跳至主要内容
临床试验/PACTR202108856656364
PACTR202108856656364尚未招募4 期

A Randomised Controlled Trial of Omega 3 Fatty Acids in the Management of Antipsychotic-Induced Movement Disorders

Dr Sammy Ohene0 个研究点目标入组 120 人开始时间: 2021年8月14日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • A confirmed diagnosis of antipsychotic-induced movement disorder
  • Participants aged between 18 and 60years.
  • On a stable dose of antipsychotic medication within 3 months prior to study
  • Patients in the control arm should not have initiated anti-cholinergic therapy
  • Patients should demonstrate a commitment not to initiate or modify interventions during the period of the study.

排除标准

  • Patients whose psychiatric disorder was not stable;
  • Patients with a significant organic neurological disorder other than the mental disorder
  • Treatment with omega-3 therapy 3months prior to study
  • Patients who were pregnant or breastfeeding.
  • Patients with a diagnosis of substance dependence (DSM-IV),
  • Patients with a known allergy to omega 3 fish oil or sea foods

研究者

发起方
Dr Sammy Ohene

相似试验